Background: The advent of new cancer therapies has engendered an increase in the
number of long-term cancer survivors. However, many of these newer therapies are …

Introduction Heart failure (HF) and cancers are two diagnoses associated with a bad
prognosis. Some data reported two decades ago that HF was as malignant as cancer …

Background: Hospice and palliative care were originally implemented for patients dying of
cancer, both of which continue to be underused in patients with heart failure (HF). The …

The longer mean survival of oncological patients has led to an increased incidence of
chemotherapy-induced cardiomyopathy. Anthracyclines and trastuzumab are the two most …

Cardio-oncology is a new field of interest in cardiology that focuses on the detection,
monitoring, and treatment of cardiovascular disease occurring as a side effect of …

Both heart failure (HF) and cancer are common and associated with substantial functional
limitations, impairment in quality of life, frequent hospitalizations, and high mortality. Yet …

Background Chemotherapeutic agents improve the cancer patients' survival but also
predispose them to cardiovascular disease, particularly heart failure (HF). This study sought …

How to build a cardio-oncology service? - Abstract - Europe PMC Sign in | Create an account
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …

Aims Cardio‐oncology clinics optimise the cardiovascular status of cancer patients but there
is a limited description of their structure, case mix, activity and results. The purpose of this …